Brief: Epkinly Receives Health Canada Approval For Adults With Follicular Lymphoma
24/09/2026 12:03
BRIEF-Epkinly Receives Health Canada Approval For Adults With Follicular Lymphoma Sept 24 (Reuters) - AbbVie Inc. ABBV.N:
EPKINLY® RECEIVES HEALTH CANADA APPROVAL FOR ADULTS WITH FOLLICULAR LYMPHOMA
Source text: ID:nCNW2Kgc3a
Further company coverage: ABBV.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AbbVie
See all newsBrief: Abbvie Reaches Agreement With The Pan-Canadian Pharmaceutical Alliance (Pcpa) For Elahere® In Platinum-Resistant Ovarian Cancer
Eli Lilly hits record high as healthcare stocks rally
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Brief: Abbvie Says Risankizumab In Ulcerative Colitis Shows Clinical Remission Rates Of 54.0%-73.1% At Week 96